´ëÇѺÎÀÎÁ¾¾çÇÐȸ Chemo-TIP Review Course 2020: Gynecologic Cancer : 2020-03-15 |
|
´ëÇѺÎÀÎÁ¾¾çÇÐȸ Chemo-TIP Review Course 2020: Gynecologic Cancer : 2020-03-15 ±³À°ÀÏÀÚ : 2020-03-15 ±³À°Àå¼Ò : ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç ±³À°ÁÖÁ¦ : Chemo-TIP Review Course 2020: Gynecologic Cancer ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ´ã´çÀÚ : ÇѼ¼¹Ì ¿¬¶ôó : 02-512-0044 À̸ÞÀÏ : office@sgo.or.kr ±³À°Á¾·ù : »êºÎÀΰú Âü¼®¿¹»óÀοø : 150¸í Èñ¸ÁÆòÁ¡ : 6Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 6 ½Ã°£ 35ºÐ ¼¼ºÎ¼ö°·á : 80,000¿ø ºñ°í Àü¹®ÀÇ 80,000 / Àü°øÀÇ,¾Ë¹ÝÀÇ 60,000 / ¿¬±¸¿ø, °£È£»ç 40,000 / ¸¸ 65¼¼ÀÌ»ó, ÁÂÀå, ¿¬ÀÚ ¹«·á ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±âŸ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 08:30~08:50 Registration () ±âŸ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 08:50~09:00 °³È¸»ç ±è½Âö(´ëÇѺÎÀÎÁ¾¾çÇÐȸ ȸÀå) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 09:00~09:20 Cervix cancer ±è¹Ì¼±(Â÷ÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 09:20~09:40 Uterine cancer À̼ºÁ¾(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 09:40~10:00 Ovarian cancer ¹éÀ̼±(¼º±Õ°üÀÇ´ë) Åä·Ð 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 10:00~10:15 Discussion () ÈÞ½Ä 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 10:15~10:35 COFFEE BREAK () ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 10:35~10:50 Special topic 1: SOLO1 & SOLO2 À̽¹Ì(°è¸íÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 10:50~11:10 Targeted agents ÀÌÁ¤À±(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 11:10~11:30 PARP inhibitors ÀÓ¸íö(±¹¸³¾Ï¼¾ÅÍ) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 11:30~11:50 Immuno-oncologics ÃÖÀ±Áø(°¡Å縯ÀÇ´ë) Åä·Ð 02-08 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 11:50~12:00 Discussion () ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 12:00~12:15 Special topic 2: Patient blood management ÀÌÁ¤Àç(¼øõÇâÀÇ´ë) ½Ä»ç 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 12:15~13:20 LUNCH () ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 13:20~13:40 Chemotherapy-induced peripheral neuropathy (CIPN) À̼øÅÂ(¼¿ïÀÇ´ë ½Å°æ°ú) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 13:40~14:00 Hematologic toxicity ÀÌÀºÁö(¼¿ïÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 14:00~14:20 Chemotherapy-induced nausea & vomiting (CINV) ¾î°æÁø(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 14:20~14:40 Hypersensitivity & septic shock ±è¼¼ÀÍ(¼¿ïÀÇ´ë) Åä·Ð 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 14:40~14:50 Discussion () ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 14:50~15:10 Special topic 3: ½É»çÆò°¡¿øÀÇ Ç×¾ÏÄ¡·á ½É»ç °æÇâ ±è¿ë¹ü(¼¿ïÀÇ´ë) Åä·Ð 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 15:10~15:15 Discussion () ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 15:15~15:30 Special topic 4: Niraparib ±è¹Ì°æ(ÀÌÈÀÇ´ë) ÈÞ½Ä 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 15:30~15:50 COFFEE BREAK () ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 15:50~16:20 Cervical cancer À̸¶¸®¾Æ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 16:20~16:50 Uterine cancer ½É½ÂÇõ(°Ç±¹ÀÇ´ë) ±³À°½Ã°£ 03-15 ¼¿ï´ëÇб³¾î¸°À̺´¿ø ÀÓ»ó °ÀÇ½Ç 16:50~17:20 Ovarian cancer ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë) |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 132 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 53 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 133 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 125 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 46 , ´ñ±Û¼ö : 0 |